Main > ONCOLOGY (**) > Lymphoma>NHL>T-Cell>CTCL>CD30+ * > TREAT.: > Co: USA. S. BrentuxiMAb Vedotin>

---

Co: USA. S. BrentuxiMAb Vedotin>'s subsections
(*) EU Approval Date: 2018. 01.22
>One Prior Systemic Therapy
Company
Patent>
TradeMark
TradeMark Web-Site

Co: USA. S. BrentuxiMAb Vedotin>'s products
This section has no products